Evolution of the Average Target: West Pharmaceutical Services, Inc.

Evolution of the Average Target - West Pharmaceutical Services, Inc.

Evolution of the Target Price: West Pharmaceutical Services, Inc.

Evolution of the Target Price - West Pharmaceutical Services, Inc.

Changes in Analyst Recommendations: West Pharmaceutical Services, Inc.

d4419b.5adOhSaiqcRI8kQsp1FCFeI8jSKqvjNUJtJ0KPi2Vi0.l8E97F_z2fF-pnwe8DgbRNMMxG39_QZjbuY-R8vfA2mtzSPgUceRsieEMw~184b96accc3afbda6c0f6a2ecfd68ea7
Nov. 02 Jefferies Adjusts West Pharmaceutical Services Price Target to $475 From $410 MT
Oct. 30 Stephens Adjusts West Pharmaceutical Services Price Target to $490 From $450 MT
Oct. 30 Deutsche Bank Adjusts West Pharmaceutical Services PT to $450 From $420, Maintains Buy Rating MT
Oct. 30 BNP Paribas Adjusts Price Target on West Pharmaceutical Services to $466 From $459 MT
Oct. 30 Rothschild & Co Redburn Adjusts Price Target on West Pharmaceutical Services to $480 From $410 MT
Oct. 28 Evercore ISI Adjusts Price Target on West Pharmaceutical Services to $425 From $440 MT
Oct. 13 TD Cowen Adjusts Price Target on West Pharmaceutical Services to $420 From $410 MT
Oct. 07 Evercore ISI Adjusts West Pharmaceutical Services Price Target to $440 From $410 MT
Oct. 06 Barclays Raises West Pharmaceutical Services Price Target to $440 From $400, Maintains Overweight Rating MT
Sep. 22 West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says MT
Sep. 22 Morgan Stanley Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $365 MT
Sep. 09 UBS Raises Price Target on West Pharmaceutical Services to $415 From $340, Keeps Buy Rating MT
Jul. 27 Evercore ISI Adjusts PT on West Pharmaceutical Services to $425 From $410, Maintains Outperform Rating MT
Jul. 27 BNP Paribas Adjusts PT on West Pharmaceutical Services to $459 From $447, Maintains Outperform Rating MT
Jul. 24 Jefferies & Co Adjusts West Pharmaceutical Services PT to $410 From $365, Maintains Buy Rating MT
Jul. 24 Rothschild & Co Redburn Adjusts West Pharmaceutical Services PT to $410 From $353, Maintains Buy Rating MT
Jul. 24 Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $420 From $405, Maintains Buy Rating MT
Jul. 20 Stephens Adjusts West Pharmaceutical Services Price Target to $410 From $360, Maintains Overweight Rating MT
Jul. 15 TD Cowen Adjusts Price Target on West Pharmaceutical Services to $410 From $365, Maintains Buy Rating MT
Jul. 13 BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target MT
Jul. 13 BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target MT
Jul. 09 Morgan Stanley Adjusts Price Target on West Pharmaceutical Services to $365 From $325 MT
Jul. 06 Evercore ISI Adjusts Price Target on West Pharmaceutical Services to $410 From $390 MT
Jul. 02 KeyBanc Adjusts PT on West Pharmaceutical Services to $390 From $350, Maintains Overweight Rating MT
Jun. 09 Barclays Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $310 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+18.73%
+15.14%
+6.31%
+9.07%
+22.49%
+13.77%
+6.33%
+3.99%
+29.66%
+17.73%
Average +14.32%
Weighted average by Cap. +13.32%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
396.69USD
Average target price
471.00USD
Spread / Average Target
+18.73%
High Price Target
500.00USD
Spread / Highest target
+26.04%
Low Price Target
340.00USD
Spread / Lowest Target
-14.29%

Analyst Consensus Detail

Analyst consensus - West Pharmaceutical Services, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - West Pharmaceutical Services, Inc.
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - West Pharmaceutical Services, Inc.
  1. Stock Market
  2. Stocks
  3. WST Stock
  4. Consensus West Pharmaceutical Services, Inc.